Scinovex
article Open AccessTop 10% cited

The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time

BMC Cancer · 2010 · Vol. 10(1) · pp. 112–112
Junliang MaLunxu LiuGuowei CheNanbin YuFuqiang DaiZongbing You

Abstract

The M1 macrophage density in the tumor islets is an independent predictor of survival time in NSCLC patients.

Immune cells in cancerEpigenetics and DNA MethylationCancer Immunotherapy and BiomarkersCD68Tumor-associated macrophageCD163StromaMacrophageSurgical oncologyMedicineLung cancerImmunohistochemistryM2 Macrophage

MeSH terms

CD68 MoleculeCD163 AntigenAgedCarcinoma, Non-Small-Cell LungFemaleHLA-DR AntigensHumansLung NeoplasmsMacrophagesMaleMiddle AgedReceptors, Cell SurfaceRetrospective StudiesTime FactorsAntigens, Differentiation, Myelomonocytic

Funding

  • U.S. Department of Defense
  • Sichuan University
  • National Institutes of Health
  • West China Hospital, Sichuan University
  • Fogarty International Center
  • National Center for Research Resources
Citations
434
FWCI
7.08
field-weighted impact
References
22
Percentile
98%
vs. same field & year
Citations per year
Cited by
Macrophage Polarization States in the Tumor Microenvironment
International Journal of Molecular Sciences · 2021 · 1,511 citations
References
Alternative activation of macrophages
Nature reviews. Immunology · 2003 · 6,118 citations
Inflammation and cancer: back to Virchow?
The Lancet · 2001 · 7,614 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.